Brief: Sunshine Biopharma Inc-On March 24, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Sunshine Biopharma

24/03/2023 20:50

March 24 (Reuters) - Sunshine Biopharma Inc  SBFM.O :
    * SUNSHINE BIOPHARMA INC-ON MARCH 24, RECEIVED NOTICE OF
DELISTING
OR FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ


Further company coverage:  SBFM.O 

 ((Reuters.Briefs@thomsonreuters.com;))